Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 22740624)

1.

Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency.

Galeotti C, Meinzer U, Quartier P, Rossi-Semerano L, Bader-Meunier B, Pillet P, Koné-Paut I.

Rheumatology (Oxford). 2012 Oct;51(10):1855-9. Epub 2012 Jun 26.

2.

On-demand anakinra treatment is effective in mevalonate kinase deficiency.

Bodar EJ, Kuijk LM, Drenth JP, van der Meer JW, Simon A, Frenkel J.

Ann Rheum Dis. 2011 Dec;70(12):2155-8. doi: 10.1136/ard.2011.149922. Epub 2011 Aug 21.

PMID:
21859689
3.

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC, Marks JB, Raskin P, Sanda S, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS; Type 1 Diabetes TrialNet Canakinumab Study Group, Pickersgill L, de Koning E, Ziegler AG, Böehm B, Badenhoop K, Schloot N, Bak JF, Pozzilli P, Mauricio D, Donath MY, Castaño L, Wägner A, Lervang HH, Perrild H, Mandrup-Poulsen T; AIDA Study Group.

Lancet. 2013 Jun 1;381(9881):1905-15. doi: 10.1016/S0140-6736(13)60023-9. Epub 2013 Apr 5.

4.

[Effectiveness of interleukin-1 inhibiton for mevalonate kinase deficiency].

Horneff G.

Z Rheumatol. 2014 Jun;73(5):398. German. No abstract available.

PMID:
25057522
5.

Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome.

de Koning HD, Schalkwijk J, van der Ven-Jongekrijg J, Stoffels M, van der Meer JW, Simon A.

Ann Rheum Dis. 2013 Oct;72(10):1634-8. doi: 10.1136/annrheumdis-2012-202192. Epub 2012 Oct 19.

PMID:
23087179
6.

Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.

Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Koné-Paut I.

Semin Arthritis Rheum. 2011 Oct;41(2):265-71. doi: 10.1016/j.semarthrit.2010.11.003. Epub 2011 Feb 1. Review.

PMID:
21277619
7.

Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.

Rigante D, Ansuini V, Bertoni B, Pugliese AL, Avallone L, Federico G, Stabile A.

Rheumatol Int. 2006 Nov;27(1):97-100. Epub 2006 Jul 27.

PMID:
16871408
8.

Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens.

Kuemmerle-Deschner JB, Wittkowski H, Tyrrell PN, Koetter I, Lohse P, Ummenhofer K, Reess F, Hansmann S, Koitschev A, Deuter C, Bialkowski A, Foell D, Benseler SM.

Arthritis Res Ther. 2013;15(3):R64.

9.

Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).

Kuemmerle-Deschner JB, Ramos E, Blank N, Roesler J, Felix SD, Jung T, Stricker K, Chakraborty A, Tannenbaum S, Wright AM, Rordorf C.

Arthritis Res Ther. 2011 Feb 28;13(1):R34. doi: 10.1186/ar3266.

10.

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes.

Kuemmerle-Deschner JB, Hachulla E, Cartwright R, Hawkins PN, Tran TA, Bader-Meunier B, Hoyer J, Gattorno M, Gul A, Smith J, Leslie KS, Jiménez S, Morell-Dubois S, Davis N, Patel N, Widmer A, Preiss R, Lachmann HJ.

Ann Rheum Dis. 2011 Dec;70(12):2095-102. doi: 10.1136/ard.2011.152728. Epub 2011 Aug 21.

PMID:
21859692
11.

Hyperimmunoglobulin D syndrome in childhood.

van der Hilst JC, Frenkel J.

Curr Rheumatol Rep. 2010 Apr;12(2):101-7. doi: 10.1007/s11926-010-0086-1. Review.

PMID:
20425018
12.

Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome.

Shendi HM, Devlin LA, Edgar JD.

J Clin Rheumatol. 2014 Mar;20(2):103-5. doi: 10.1097/01.RHU.0000442576.41537.de.

PMID:
24561416
13.

Canakinumab in Schnitzler syndrome.

Vanderschueren S, Knockaert D.

Semin Arthritis Rheum. 2013 Feb;42(4):413-6. doi: 10.1016/j.semarthrit.2012.06.003. Epub 2012 Aug 15.

PMID:
22901459
14.

Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.

Russo RA, Melo-Gomes S, Lachmann HJ, Wynne K, Rajput K, Eleftheriou D, Edelsten C, Hawkins PN, Brogan PA.

Rheumatology (Oxford). 2014 Apr;53(4):665-70. doi: 10.1093/rheumatology/ket415. Epub 2013 Dec 17.

PMID:
24352339
15.

Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.

Normand S, Massonnet B, Delwail A, Favot L, Cuisset L, Grateau G, Morel F, Silvain C, Lecron JC.

Eur Cytokine Netw. 2009 Sep;20(3):101-7. doi: 10.1684/ecn.2009.0163. Review.

PMID:
19825518
16.

Severe early-onset colitis revealing mevalonate kinase deficiency.

Levy M, Arion A, Berrebi D, Cuisset L, Jeanne-Pasquier C, Bader-Meunier B, Jung C.

Pediatrics. 2013 Sep;132(3):e779-83. doi: 10.1542/peds.2012-3344. Epub 2013 Aug 26.

17.

The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease.

Kontzias A, Efthimiou P.

Semin Arthritis Rheum. 2012 Oct;42(2):201-5. doi: 10.1016/j.semarthrit.2012.03.004. Epub 2012 Apr 17.

PMID:
22512815
18.

Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study.

Koné-Paut I, Lachmann HJ, Kuemmerle-Deschner JB, Hachulla E, Leslie KS, Mouy R, Ferreira A, Lheritier K, Patel N, Preiss R, Hawkins PN; Canakinumab in CAPS Study Group.

Arthritis Res Ther. 2011;13(6):R202. doi: 10.1186/ar3535. Epub 2011 Dec 9.

19.

Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.

Shendi HM, Walsh D, Edgar JD.

Rheumatol Int. 2012 Jan;32(1):249-51. doi: 10.1007/s00296-009-1322-8. Epub 2009 Dec 18.

PMID:
20020131
20.

Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.

van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A; International HIDS Study Group.

Medicine (Baltimore). 2008 Nov;87(6):301-10. doi: 10.1097/MD.0b013e318190cfb7.

PMID:
19011501
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk